2,4-PDCA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 527658

CAS#: 499-80-9

Description: 2,4-PDCA is a potent inhibitor of several Jumonji domain-containing lysine demethylases.

Chemical Structure

img
2,4-PDCA
CAS# 499-80-9
Instruction

Theoretical Analysis

MedKoo Cat#: 527658
Name: 2,4-PDCA
CAS#: 499-80-9
Chemical Formula: C7H5NO4
Exact Mass: 167.02
Molecular Weight: 167.120
Elemental Analysis: C, 50.31; H, 3.02; N, 8.38; O, 38.29

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: 2,4PDCA; 2,4 PDCA; 2,4-PDCA

IUPAC/Chemical Name: 2,4-Pyridinedicarboxylic acid

InChi Key: MJIVRKPEXXHNJT-UHFFFAOYSA-N

InChi Code: InChI=1S/C7H5NO4/c9-6(10)4-1-2-8-5(3-4)7(11)12/h1-3H,(H,9,10)(H,11,12)

SMILES Code: O=C(C1=NC=CC(C(O)=O)=C1)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 167.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Mishur RJ, Khan M, Munkácsy E, Sharma L, Bokov A, Beam H, Radetskaya O, Borror M, Lane R, Bai Y, Rea SL. Mitochondrial metabolites extend lifespan. Aging Cell. 2016 Apr;15(2):336-48. doi: 10.1111/acel.12439. Epub 2016 Jan 5. PubMed PMID: 26729005; PubMed Central PMCID: PMC4783347.

2: Korczynska M, Le DD, Younger N, Gregori-Puigjané E, Tumber A, Krojer T, Velupillai S, Gileadi C, Nowak RP, Iwasa E, Pollock SB, Ortiz Torres I, Oppermann U, Shoichet BK, Fujimori DG. Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors. J Med Chem. 2016 Feb 25;59(4):1580-98. doi: 10.1021/acs.jmedchem.5b01527. Epub 2015 Dec 23. PubMed PMID: 26699912; PubMed Central PMCID: PMC5080985.

3: Qi H, Jing Z, Xiaolin W, Changwu X, Xiaorong H, Jian Y, Jing C, Hong J. Histone Demethylase JMJD2A Inhibition Attenuates Neointimal Hyperplasia in the Carotid Arteries of Balloon-Injured Diabetic Rats via Transcriptional Silencing: Inflammatory Gene Expression in Vascular Smooth Muscle Cells. Cell Physiol Biochem. 2015;37(2):719-34. doi: 10.1159/000430390. Epub 2015 Sep 11. PubMed PMID: 26356263.

4: Horita S, Scotti JS, Thinnes C, Mottaghi-Taromsari YS, Thalhammer A, Ge W, Aik W, Loenarz C, Schofield CJ, McDonough MA. Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases. Structure. 2015 Apr 7;23(4):639-52. doi: 10.1016/j.str.2015.01.014. Epub 2015 Feb 26. PubMed PMID: 25728928; PubMed Central PMCID: PMC4396695.

5: Sham A, Martinez EC, Beyer S, Trau DW, Raghunath M. Incorporation of a prolyl hydroxylase inhibitor into scaffolds: a strategy for stimulating vascularization. Tissue Eng Part A. 2015 Mar;21(5-6):1106-15. doi: 10.1089/ten.TEA.2014.0077. Epub 2015 Jan 14. PubMed PMID: 25370818; PubMed Central PMCID: PMC4356217.

6: An X, Wang H, Li G. Structures and Luminescent Properties of Two 2D Coordination Polymers Containing Tb(III) or Dy(III) Ions. J Fluoresc. 2014 Mar;24(2):425-9. doi: 10.1007/s10895-013-1308-5. Epub 2013 Oct 5. PubMed PMID: 24091805.

7: Hopkinson RJ, Tumber A, Yapp C, Chowdhury R, Aik W, Che KH, Li XS, Kristensen JBL, King ONF, Chan MC, Yeoh KK, Choi H, Walport LJ, Thinnes CC, Bush JT, Lejeune C, Rydzik AM, Rose NR, Bagg EA, McDonough MA, Krojer T, Yue WW, Ng SS, Olsen L, Brennan PE, Oppermann U, Muller-Knapp S, Klose RJ, Ratcliffe PJ, Schofield CJ, Kawamura A. 5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation. Chem Sci. 2013 Aug 1;4(8):3110-3117. doi: 10.1039/C3SC51122G. PubMed PMID: 26682036; PubMed Central PMCID: PMC4678600.

8: Sayegh J, Cao J, Zou MR, Morales A, Blair LP, Norcia M, Hoyer D, Tackett AJ, Merkel JS, Yan Q. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. J Biol Chem. 2013 Mar 29;288(13):9408-17. doi: 10.1074/jbc.M112.419861. Epub 2013 Feb 13. PubMed PMID: 23408432; PubMed Central PMCID: PMC3611010.

9: Schley G, Klanke B, Schödel J, Kröning S, Türkoglu G, Beyer A, Hagos Y, Amann K, Burckhardt BC, Burzlaff N, Eckardt KU, Willam C. Selective stabilization of HIF-1α in renal tubular cells by 2-oxoglutarate analogues. Am J Pathol. 2012 Nov;181(5):1595-606. doi: 10.1016/j.ajpath.2012.07.010. Epub 2012 Aug 31. PubMed PMID: 22944601.

10: Hagos Y, Schley G, Schödel J, Krick W, Burckhardt G, Willam C, Burckhardt BC. α-Ketoglutarate-related inhibitors of HIF prolyl hydroxylases are substrates of renal organic anion transporters 1 (OAT1) and 4 (OAT4). Pflugers Arch. 2012 Oct;464(4):367-74. Epub 2012 Aug 9. PubMed PMID: 22875277.

11: Rakić GM, Grgurić-Šipka S, Kaluđerović GN, Bette M, Filipović L, Aranđelović S, Radulović S, Tešić ZLj. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines. Eur J Med Chem. 2012 Sep;55:214-9. doi: 10.1016/j.ejmech.2012.07.019. Epub 2012 Jul 22. PubMed PMID: 22858225.

12: Kristensen LH, Nielsen AL, Helgstrand C, Lees M, Cloos P, Kastrup JS, Helin K, Olsen L, Gajhede M. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor. FEBS J. 2012 Jun;279(11):1905-14. doi: 10.1111/j.1742-4658.2012.08567.x. Epub 2012 May 2. PubMed PMID: 22420752.

13: Gligorijević N, Aranđelović S, Filipović L, Jakovljević K, Janković R, Grgurić-Šipka S, Ivanović I, Radulović S, Tešić ZLj. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure. J Inorg Biochem. 2012 Mar;108:53-61. doi: 10.1016/j.jinorgbio.2011.12.002. Epub 2011 Dec 16. PubMed PMID: 22266461.

14: Hutchinson SE, Leveridge MV, Heathcote ML, Francis P, Williams L, Gee M, Munoz-Muriedas J, Leavens B, Shillings A, Jones E, Homes P, Baddeley S, Chung CW, Bridges A, Argyrou A. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry. J Biomol Screen. 2012 Jan;17(1):39-48. doi: 10.1177/1087057111416660. Epub 2011 Aug 21. PubMed PMID: 21859681.

15: Lushnikova I, Orlovsky M, Dosenko V, Maistrenko A, Skibo G. Brief anoxia preconditioning and HIF prolyl-hydroxylase inhibition enhances neuronal resistance in organotypic hippocampal slices on model of ischemic damage. Brain Res. 2011 Apr 22;1386:175-83. doi: 10.1016/j.brainres.2011.02.033. Epub 2011 Feb 19. PubMed PMID: 21338581.

16: Mackeen MM, Kramer HB, Chang KH, Coleman ML, Hopkinson RJ, Schofield CJ, Kessler BM. Small-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry. J Proteome Res. 2010 Aug 6;9(8):4082-4092. doi: 10.1021/pr100269b. PubMed PMID: 20583823; PubMed Central PMCID: PMC4681095.

17: Sander JR, Bucar DK, Henry RF, Baltrusaitis J, Zhang GG, MacGillivray LR. A red zwitterionic co-crystal of acetaminophen and 2,4-pyridinedicarboxylic acid. J Pharm Sci. 2010 Sep;99(9):3676-83. doi: 10.1002/jps.22229. PubMed PMID: 20574998.

18: Vlad F, Tiainen P, Owen C, Spano T, Daher FB, Oualid F, Senol NO, Vlad D, Myllyharju J, Kalaitzis P. Characterization of two carnation petal prolyl 4 hydroxylases. Physiol Plant. 2010 Oct;140(2):199-207. doi: 10.1111/j.1399-3054.2010.01390.x. PubMed PMID: 20553416.

19: Grgurić-Sipka S, Ivanović I, Rakić G, Todorović N, Gligorijević N, Radulović S, Arion VB, Keppler BK, Tesić ZLj. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity. Eur J Med Chem. 2010 Mar;45(3):1051-8. doi: 10.1016/j.ejmech.2009.11.055. Epub 2009 Dec 16. PubMed PMID: 20053483.

20: Raghunath M, Sy Wong Y, Farooq M, Ge R. Pharmacologically induced angiogenesis in transgenic zebrafish. Biochem Biophys Res Commun. 2009 Jan 23;378(4):766-71. doi: 10.1016/j.bbrc.2008.11.127. Epub 2008 Dec 7. PubMed PMID: 19068208.